Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON40044
NL-OMON40044
Completed
Phase 2

A randomized, double-blind, parallel group study to evaluate metabolic effects of LCZ696 and amlodipine in obese hypertensive subjects: the CLCZ696B2207 study - The CLCZ696B2207 study

Medisch Universitair Ziekenhuis Maastricht0 sites28 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInsulin sensitivitymetabolism1001842410013317

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Insulin sensitivity
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
28
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
July 5, 2013
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • •Obese people (\>\= 18 years old) with mild to moderate essential hypertension with non\-childbearing potential

Exclusion Criteria

  • •use of other medication, pregnancy, lactating women, history of angioedema, heavy hypertention (grade 3 of the WHO classification)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
A randomised, double-blind, controlled, parallel-group, multi-country study to investigate the effect of a partially hydrolysed infant formula with added synbiotics on gut microbiota composition and clinical effectiveness in infants at high risk of developing allergy.infants at high risk of developing allergy10001708
NL-OMON50109utricia44
Completed
Phase 4
A randomized, multicentre, double-blind, parallel, sham-controlled study of the gammaCore®, a non-invasive neurostimulator device for the acute relief of episodic and chronic cluster headache.cluster headaches10019231
NL-OMON40599electroCore LLC35
Completed
Phase 2
A randomised, controlled, double-blind trial to investigate the effects of a new infant formula on growth, tolerance and safety in healthy term infants.effect op de groei van zuigelingeneffects on growth
NL-OMON39783utricia Research - Centre for Specialised Nutrition121
Completed
Phase 2
A Randomised, Parallel, Double-Blind, Placebo-Controlled Phase 2b Study to Assess the Safety, Tolerability and Efficacy of AZD8233 Treatment in Participants with Hyperlipidaemia (SOLANO)High Blood Cholesterol levelsHyperlipidaemia100822061001331710003216
NL-OMON52196Astra Zeneca26
Completed
Phase 3
A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, 12-Week Study of Pitavastatin in High-Risk Hyperlipidaemia in Childhood P/266/2011, P267/2011, P268/2011hyperlipidemiehigh cholesterolHyperlipidaemia
NL-OMON37577Kowa Research Europe40